| JYHB2200007 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2022-01-11 | | | | | view |
| JYHB2200006 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2022-01-11 | | | | | view |
| CYHB2100174 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs(4) | Supplementary Application | 2021-01-25 | 常州恒邦药业有限公司 | Changzhou Humon Pharmaceutical Co Ltd | Certificate Issued | 2021-03-03 | view |
| JYHZ2000285 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2022-01-20 | view |
| JYHZ2000284 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | License Renew | 2021-01-05 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2022-01-20 | view |
| CYHS2000795 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs(4) | Generic Drug | 2020-11-19 | 山东孔府制药有限公司 | Shandong Gonfucius Pharmaceutical Co Ltd | In Review | 2020-11-18 | view |
| JYHB2001889 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2021-03-25 | view |
| JYHB2001888 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-09-27 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | In Review | 2020-09-25 | view |
| JYHB2001439 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-09-01 | view |
| JYHB2001438 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-08-21 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Filed | 2020-09-01 | view |
| JYHB2000485 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-05-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-07-29 | view |
| JYHB2000484 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2020-05-08 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-07-29 | view |
| JYHB1900843 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2019-07-31 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-02-03 | view |
| JYHB1900845 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs | Supplementary Application | 2019-07-22 | 葛兰素史克（中国）投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd | Certificate Issued | 2020-02-03 | view |
| CYHS1700158 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs(4) | Generic Drug | 2019-06-25 | 江苏嘉逸医药有限公司 | Jiangsu Jiayi Pharmaceutical Co Ltd | Certificate Issued | 2021-09-02 | view |
| CYHS1700157 | 安立生坦 | ambrisentan | Active ingredient | Chemical Drugs(3) | Generic Drug | 2019-05-09 | 江苏嘉逸医药有限公司 | Jiangsu Jiayi Pharmaceutical Co Ltd | In Review | 2019-05-08 | view |
| CYHS1900028 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs(4) | Generic Drug | 2019-01-26 | 武汉人福药业有限责任公司 | Wuhan Humanwell Pharmaceutical Co Ltd | Certificate Issued | 2020-12-23 | view |
| CYHS1800101 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs(4) | Generic Drug | 2018-06-08 | 江苏德源药业股份有限公司 | Jiangsu Deyuan Pharmaceutical Co Ltd | Certificate Issued | 2020-12-30 | view |
| CYHS1700559 | 安立生坦 | ambrisentan | Active ingredient | Chemical Drugs(3) | Generic Drug | 2018-06-06 | 浙江华海药业股份有限公司 | Zhe JIANG HUA HAI Pharmaceutical Co Ltd | In Review | 2018-06-04 | view |
| CYHS1700560 | 安立生坦片 | ambrisentan | Tablet | Chemical Drugs(4) | Generic Drug | 2017-12-28 | 浙江华海药业股份有限公司 | Zhe JIANG HUA HAI Pharmaceutical Co Ltd | Certificate Issued | 2020-01-06 | view |
